Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros

País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
N Engl J Med ; 389(19): 1766-1777, 2023 Nov 09.
Artigo em Inglês | MEDLINE | ID: mdl-37815935

RESUMO

BACKGROUND: Nursing home residents are at high risk for infection, hospitalization, and colonization with multidrug-resistant organisms. METHODS: We performed a cluster-randomized trial of universal decolonization as compared with routine-care bathing in nursing homes. The trial included an 18-month baseline period and an 18-month intervention period. Decolonization entailed the use of chlorhexidine for all routine bathing and showering and administration of nasal povidone-iodine twice daily for the first 5 days after admission and then twice daily for 5 days every other week. The primary outcome was transfer to a hospital due to infection. The secondary outcome was transfer to a hospital for any reason. An intention-to-treat (as-assigned) difference-in-differences analysis was performed for each outcome with the use of generalized linear mixed models to compare the intervention period with the baseline period across trial groups. RESULTS: Data were obtained from 28 nursing homes with a total of 28,956 residents. Among the transfers to a hospital in the routine-care group, 62.2% (the mean across facilities) were due to infection during the baseline period and 62.6% were due to infection during the intervention period (risk ratio, 1.00; 95% confidence interval [CI], 0.96 to 1.04). The corresponding values in the decolonization group were 62.9% and 52.2% (risk ratio, 0.83; 95% CI, 0.79 to 0.88), for a difference in risk ratio, as compared with routine care, of 16.6% (95% CI, 11.0 to 21.8; P<0.001). Among the discharges from the nursing home in the routine-care group, transfer to a hospital for any reason accounted for 36.6% during the baseline period and for 39.2% during the intervention period (risk ratio, 1.08; 95% CI, 1.04 to 1.12). The corresponding values in the decolonization group were 35.5% and 32.4% (risk ratio, 0.92; 95% CI, 0.88 to 0.96), for a difference in risk ratio, as compared with routine care, of 14.6% (95% CI, 9.7 to 19.2). The number needed to treat was 9.7 to prevent one infection-related hospitalization and 8.9 to prevent one hospitalization for any reason. CONCLUSIONS: In nursing homes, universal decolonization with chlorhexidine and nasal iodophor led to a significantly lower risk of transfer to a hospital due to infection than routine care. (Funded by the Agency for Healthcare Research and Quality; Protect ClinicalTrials.gov number, NCT03118232.).


Assuntos
Anti-Infecciosos Locais , Infecções Assintomáticas , Clorexidina , Infecção Hospitalar , Casas de Saúde , Povidona-Iodo , Humanos , Administração Cutânea , Administração Intranasal , Anti-Infecciosos Locais/administração & dosagem , Anti-Infecciosos Locais/uso terapêutico , Banhos , Clorexidina/administração & dosagem , Clorexidina/uso terapêutico , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/prevenção & controle , Infecção Hospitalar/terapia , Hospitalização/estatística & dados numéricos , Casas de Saúde/estatística & dados numéricos , Transferência de Pacientes/estatística & dados numéricos , Povidona-Iodo/administração & dosagem , Povidona-Iodo/uso terapêutico , Higiene da Pele/métodos , Infecções Assintomáticas/terapia
2.
Molecules ; 26(7)2021 Mar 26.
Artigo em Inglês | MEDLINE | ID: mdl-33810292

RESUMO

Biofilms play an essential role in chronic and healthcare-associated infections and are more resistant to antimicrobials compared to their planktonic counterparts due to their (1) physiological state, (2) cell density, (3) quorum sensing abilities, (4) presence of extracellular matrix, (5) upregulation of drug efflux pumps, (6) point mutation and overexpression of resistance genes, and (7) presence of persister cells. The genes involved and their implications in antimicrobial resistance are well defined for bacterial biofilms but are understudied in fungal biofilms. Potential therapeutics for biofilm mitigation that have been reported include (1) antimicrobial photodynamic therapy, (2) antimicrobial lock therapy, (3) antimicrobial peptides, (4) electrical methods, and (5) antimicrobial coatings. These approaches exhibit promising characteristics for addressing the impending crisis of antimicrobial resistance (AMR). Recently, advances in the micro- and nanotechnology field have propelled the development of novel biomaterials and approaches to combat biofilms either independently, in combination or as antimicrobial delivery systems. In this review, we will summarize the general principles of clinically important microbial biofilm formation with a focus on fungal biofilms. We will delve into the details of some novel micro- and nanotechnology approaches that have been developed to combat biofilms and the possibility of utilizing them in a clinical setting.


Assuntos
Antifúngicos , Materiais Biocompatíveis , Biofilmes , Infecção Hospitalar/terapia , Farmacorresistência Fúngica/efeitos dos fármacos , Fungos , Nanopartículas/uso terapêutico , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Bandagens , Materiais Biocompatíveis/farmacologia , Materiais Biocompatíveis/uso terapêutico , Biofilmes/efeitos dos fármacos , Biofilmes/crescimento & desenvolvimento , Fungos/efeitos dos fármacos , Fungos/fisiologia , Humanos
3.
Eur J Pediatr ; 168(11): 1343-8, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19205732

RESUMO

Rotavirus (RV) is a frequent cause of severe gastroenteritis (GE) in children. With the licensure of new RV vaccines, data on the burden of disease are important regarding immunization strategies. We reviewed the medical records of children hospitalized with RV infection in our institution between July 2002 and March 2006. Relevant data were extracted in a standardized fashion from records of hospitalized children with a positive RV antigen test in a stool sample. Severity of disease was graded by the 20-point Vesikari score. Population data were obtained from the Federal Office of Statistics. Six hundred eighty-six RVGE were identified and records of 608 hospitalizations (in 607 children) were available. In 539 (89%) cases, RVGE was the primary reason for hospitalization and 69 (11%) were nosocomial infections; yearly peaks occurred between February and May. Cumulative incidence of RVGE was 26.7/1,000 children <3 years of age. Median age of 539 children (55.6% male) with primary RVGE was 1.4 years and median stay in the hospital for both community acquired and nosocomial RVGE was 4 days (interquartile range 3-5). Thirtypercent and 94% of RV hospitalizations were in children <1 and <3 years of age, respectively. Mean Vesikari score was 15 (range 6-20; 96% >11). Intravenous fluids were administered in 378 (70%) patients, 130 (24%) patients were rehydrated via nasogastral tube, and 31 (5.7%) received rehydration by mouth. RVGE causes a substantial burden in children with an estimated risk for hospitalization due to RVGE of one in 37 children <3 years of age.


Assuntos
Infecção Hospitalar/diagnóstico , Gastroenterite/diagnóstico , Infecções por Rotavirus/diagnóstico , Pré-Escolar , Infecções Comunitárias Adquiridas/diagnóstico , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/terapia , Infecção Hospitalar/virologia , Feminino , Hidratação/métodos , Gastroenterite/epidemiologia , Gastroenterite/terapia , Gastroenterite/virologia , Hospitalização/estatística & dados numéricos , Hospitais Pediátricos , Humanos , Incidência , Lactente , Tempo de Internação/estatística & dados numéricos , Masculino , Prontuários Médicos/estatística & dados numéricos , Estudos Retrospectivos , Infecções por Rotavirus/epidemiologia , Infecções por Rotavirus/terapia , Infecções por Rotavirus/virologia , Estações do Ano , Índice de Gravidade de Doença , Suíça/epidemiologia , Resultado do Tratamento
4.
Expert Rev Clin Pharmacol ; 12(7): 635-642, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31092053

RESUMO

Introduction: The rise of antibiotic resistance, the limited efficacy and the adverse events associated with antibiotics have urged the development of alternative measures to treat bacterial infections. Novel therapies which are pathogen specific and are safer to the healthy microbiome are being developed. Areas covered: This manuscript provides a compact overview of the feasibility and clinical impact of the latest novel therapies, with a focus on monoclonal antibodies (mAbs), vaccines, stem cells, bacteriophages, and liposomes. This is a follow-up of a previous manuscript (doi: 10.1080/17512433.2016.1241141); a database search (PubMed, EMBASE, Cochrane) was used to identify recently published literature (from January 2016) which was not covered in the previous publication. Expert opinion: Among non-traditional agents, monoclonal antibodies have not been as successful as in other therapeutic areas. In particular many are developed to prevent hospital-acquired infections caused by S. aureus or P. aeruginosa and, so far, results have been overall disappointing. Stem cells and bacteriophages still have a long way to go. Vaccines are always desirable to prevent infections but again there is a lack of confirmatory results. Broad spectrum liposomes have shown promising results in treating severely infected patients and could be game changers in patient management.


Assuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/terapia , Infecção Hospitalar/terapia , Animais , Antibacterianos/efeitos adversos , Antibacterianos/farmacologia , Anticorpos Monoclonais/uso terapêutico , Infecções Bacterianas/microbiologia , Vacinas Bacterianas/administração & dosagem , Bacteriófagos , Infecção Hospitalar/microbiologia , Farmacorresistência Bacteriana , Humanos , Lipossomos , Células-Tronco/citologia
5.
J Dent Hyg ; 90 Suppl 1: 15-21, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27458314

RESUMO

PURPOSE: The U.S. spends an average of $6.5 billion each year to treat patients who suffer from pneumonia. Pneumonia currently has the highest morbidity and mortality rates of all nosocomial infections, is hypothesized to account for 15% of all hospital-acquired illnesses and is responsible for 13 to 48% of all nursing home-associated illnesses. For years, researchers have tried to develop methods to prevent pneumonia because of its detrimental effects on the body, but only in the last decade have they been able to uncover possible methods to do so. Inadequate oral hygiene care is one of the ways that elderly patients contract hospital-acquired pneumonia (HAP). Proper oral disease prevention could possibly be considered the standard of care in long-term stay facilities to reduce and prevent elderly patients from contracting HAP. The purpose of this literature review is to explore the relationship between oral health care practices and HAP.


Assuntos
Infecção Hospitalar/fisiopatologia , Saúde Bucal , Higiene Bucal/métodos , Doenças Periodontais/complicações , Pneumonia Bacteriana/fisiopatologia , Fatores Etários , Idoso , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/prevenção & controle , Infecção Hospitalar/terapia , Higienistas Dentários , Humanos , Doenças da Boca/complicações , Doenças da Boca/prevenção & controle , Higiene Bucal/enfermagem , Doenças Periodontais/terapia , Pneumonia Bacteriana/epidemiologia , Pneumonia Bacteriana/prevenção & controle , Pneumonia Bacteriana/terapia , Fatores de Risco , Estados Unidos/epidemiologia
7.
Am J Surg ; 169(5): 480-3, 1995 May.
Artigo em Inglês | MEDLINE | ID: mdl-7747823

RESUMO

BACKGROUND: Colitis caused by Clostridium difficile is receiving increased attention as a nosocomial hospital-acquired infection. METHODS: To determine the incidence of C difficile colitis in our facility and the relative proportion of patients dying from the colitis or requiring colectomy for it, we retrospectively reviewed 201 cases of colitis caused by C difficile from 1984 to 1994. RESULTS: The incidence of C difficile colitis appears to be sharply increasing and is associated with the use of cephalosporins. Among patients who subsequently developed C difficile colitis, the most frequent indication for antibiotic use was perioperative prophylaxis; surgical patients comprised 55% of the total cases. Surgical intervention was required for 5% of patients with C difficile colitis, with an operative mortality of 30%. The overall mortality was 3.5% and was associated with a delay in diagnosis. The only discriminative factor between patients who died and those who survived was length of time from symptoms to treatment--5.43 days for survivors versus 10.7 days for those who died (P < 0.05). CONCLUSIONS: Most cases of C difficile colitis seen by surgeons have followed the use of perioperative prophylactic antibiotics. Strict guidelines for using perioperative antibiotics should be observed. Prompt recognition of C difficile colitis and aggressive therapy for it are essential for a favorable outcome.


Assuntos
Infecção Hospitalar/epidemiologia , Enterocolite Pseudomembranosa/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Cefalosporinas/efeitos adversos , Cefalosporinas/uso terapêutico , Criança , Pré-Escolar , Resina de Colestiramina/uso terapêutico , Infecção Hospitalar/etiologia , Infecção Hospitalar/terapia , Quimioterapia Combinada , Enterocolite Pseudomembranosa/etiologia , Enterocolite Pseudomembranosa/terapia , Feminino , Hidratação , Mortalidade Hospitalar , Humanos , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Incidência , Lactente , Masculino , Metronidazol/uso terapêutico , Pessoa de Meia-Idade , Pré-Medicação/efeitos adversos , Estudos Retrospectivos , Procedimentos Cirúrgicos Operatórios/métodos , Taxa de Sobrevida , Vancomicina/uso terapêutico
8.
Nihon Geka Gakkai Zasshi ; 105(11): 716-9, 2004 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-15565903

RESUMO

This article reviews the epidemiology, risk factors, pathogenesis, diagnosis, treatment, and prophylaxis of ventilator-associated pneumonia (VAP), which is one of the most important infectious complications during the perioperative period. The definition of VAP is a nosocomial pneumonia occurring more than 48 h after endotracheal intubation and initiation of mechanical ventilation. Early liberation from the ventilator and the use of non-invasive positive-pressure ventilation are useful in preventing VAP. The early institution of appropriate antimicrobial therapy contributes to a good outcome. The initial therapy to ensure adequate coverage of potentially infective organisms should be accompanied by deescalation, or discontinuation, when the microbiological data became available. Useful preventative strategies include subglottic suctioning of pooled secretions just above the endotracheal tube cuff and oral care because of the pathogenesis of VAP.


Assuntos
Infecção Hospitalar/prevenção & controle , Contaminação de Equipamentos/prevenção & controle , Pneumonia Bacteriana/prevenção & controle , Complicações Pós-Operatórias/prevenção & controle , Ventiladores Mecânicos/efeitos adversos , Ventiladores Mecânicos/microbiologia , Antibacterianos/administração & dosagem , Infecção Hospitalar/diagnóstico , Infecção Hospitalar/etiologia , Infecção Hospitalar/terapia , Descontaminação , Desinfecção , Humanos , Assistência Perioperatória , Pneumonia Bacteriana/diagnóstico , Pneumonia Bacteriana/etiologia , Pneumonia Bacteriana/terapia , Respiração com Pressão Positiva , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/terapia , Fatores de Risco , Saliva , Esterilização , Sucção , Desmame do Respirador
9.
J Microbiol Biotechnol ; 21(6): 659-64, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21715974

RESUMO

Staphylococcus aureus (SA) bacteremia is associated with high mortality, and often results in metastatic infections. The methicillin-resistant SA (MRSA) is an urgent health care issue, as nosocomial infections with these bacteria represent limited treatment alternatives. Samples of whole blood containing challenge inoculums of SA and MRSA strains were passed through columns packed with surface-heparinized polyethylene beads. The bound bacteria were eluted and quantitatively determined by culturing and by real-time PCR. Significant amounts of both SA and MRSA adhered to the heparinized beads (more than 65% of inoculated bacteria). After rinsing with buffer at high ionic strength, viable bacteria or bacterial DNA were eluted from the columns, indicating that the binding was specific. The conclusions that can be made from these experiments are that, as earlier reported in the literature, the high affinity of SA to heparin is retained in whole blood, and MRSA in whole blood binds to heparin with similar or higher affinity than SA. It should be possible to lower the amount of SA and/or MRSA from the blood of infected patients to levels that could be taken care of by the immune system. In previous studies, we have shown that passing blood from septic patients over beads coated with end-point-attached, biologically active heparin is a useful technique for regulating the levels of heparin-binding cytokine. These findings in combination with the present findings indicate the possibility of creating an apheresis technology for treatment of sepsis caused by SA and/or MRSA.


Assuntos
Bacteriemia/terapia , Biotecnologia/métodos , Remoção de Componentes Sanguíneos/métodos , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Infecções Estafilocócicas/terapia , Staphylococcus aureus/isolamento & purificação , Bacteriemia/microbiologia , Aderência Bacteriana , Contagem de Colônia Microbiana , Infecção Hospitalar/microbiologia , Infecção Hospitalar/terapia , Heparina/metabolismo , Humanos , Imobilização , Staphylococcus aureus Resistente à Meticilina/genética , Staphylococcus aureus Resistente à Meticilina/metabolismo , Microesferas , Polietileno/química , Reação em Cadeia da Polimerase/métodos , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/genética , Staphylococcus aureus/metabolismo
11.
Braz. j. otorhinolaryngol. (Impr.) ; Braz. j. otorhinolaryngol. (Impr.);78(4): 35-41, jul.-ago. 2012. ilus, tab
Artigo em Português | LILACS | ID: lil-646768

RESUMO

A rinossinusite é uma das principais causas de febre em pacientes críticos e deve ser sistematicamente pesquisada. OBJETIVO: Avaliar o impacto da punção do seio maxilar à beira leito, no diagnóstico e no tratamento dos pacientes com rinossinusite infecciosa internados em Unidade de Terapia Intensiva de um hospital universitário de alta complexidade. MATERIAIS E MÉTODOS: Estudo retrospectivo que avaliou os pacientes em ventilação mecânica com febre de origem indeterminada e sinais tomográficos de rinossinusite submetidos à punção do seio maxilar pelo meato inferior. RESULTADOS: A amostra total do estudo consistiu de 27 pacientes (70,3% do sexo masculino com média de idade 45,3 anos). Os diagnósticos de admissão mais frequentes na Unidade de Terapia Intensiva foram Trauma Crânio Encefálico e Acidente Vascular Cerebral. No exame tomográfico, os seios paranasais mais acometidos foram o maxilar, em 85,2%, e esfenoidal, em 74,1%. A secreção purulenta foi visualizada no meato médio em 30,7% das fossas nasais. Os microrganismos mais frequentes nos aspirados dos seios foram Pseudomonas aeruginosa e Acinetobacter baumannii. CONCLUSÃO: A punção do seio maxilar à beira leito demonstrou-se uma importante ferramenta diagnóstica e terapêutica nos pacientes de UTI com rinossinusite hospitalar, submetidos à ventilação mecânica invasiva.


Rhinosinusitis is one of the most commom causes of fever of unknown origin in critically ill patients and should be systematically searched. OBJECTIVE: This study aims to evaluate the diagnostic and therapeutic effect of maxillary sinus puncture performed at the bedside in patients with infective rhinosinusitis hospitalized in an Intensive Care Unit of a high complexity care hospital. MATERIALS AND METHODS: This retrospective study looks into patients on mechanical ventilation with fever of unknown origin and signs of rhinosinusitis on CT images who were submitted to inferior meatus maxillary sinus puncture. RESULTS: The total study sample consisted of 27 patients (70.3% male; mean age 45.3 years). The most common Intensive Care Unit admission diagnoses were head trauma and stroke. CT scans revealed the maxillary (85.2%) and sphenoid (74.1%) sinuses were the most involved paranasal sinuses. Middle meatus purulent drainage was seen in 30.7% of the nasal cavities. Fever was reduced in 70.4% of the patients after puncture (p < 0.001). The most commonly found organisms in sinus aspirates were Pseudomonas aeruginosa and Acinetobacter baumannii. CONCLUSION: Maxillary sinus puncture performed at the bedside of the patients is an important diagnostic and theraupetic tool for critically ill patients.


Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecção Hospitalar/diagnóstico , Rinite/diagnóstico , Sinusite/diagnóstico , Infecção Hospitalar/microbiologia , Infecção Hospitalar/terapia , Unidades de Terapia Intensiva , Punções , Estudos Retrospectivos , Rinite/microbiologia , Rinite/terapia , Sinusite/microbiologia , Sinusite/terapia
12.
J Hand Surg Am ; 4(1): 90-4, 1979 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-759512

RESUMO

Ten cases of herpes simplex infections of a digit were observed during a 3 year period. The diagnosis was confirmed in seven cases by culture or tests of serum antibodies. In three cases the clinical characteristics were sufficient to suggest the diagnosis. Medical and dental personnel are particularly prone to develop this affliction; their occupations are a frequent clue to the diagnosis. Nonsurgical treatment of this self-limited entity is recommended.


Assuntos
Dedos , Herpes Simples/diagnóstico , Adulto , Infecção Hospitalar/diagnóstico , Infecção Hospitalar/terapia , Herpes Simples/terapia , Humanos , Lactente , Masculino , Doenças Profissionais/diagnóstico , Doenças Profissionais/terapia , Recursos Humanos em Hospital
13.
Klin Monbl Augenheilkd ; 174(3): 456-61, 1979 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-480819

RESUMO

101 patients with epidemic keratoconjunctivitis were treated with different eye drops: cortisone, antibiotics and P.V.P.-Iodine. The treatment of 19 patients with P.V.P.-Iodine showed that inflammatory symptoms disappeared rapidly; corneal complications however such as superficial keratitis could not be prevented. After the outbreak of epidemic keratoconjunctivitis, severe hygienic measures had been taken at the eye-clinic. On account of the hygienic prophylactic measures further infections could be prevented at the clinic almost completely.


Assuntos
Infecção Hospitalar/terapia , Surtos de Doenças , Ceratoconjuntivite/terapia , Administração Tópica , Áustria , Betametasona/administração & dosagem , Infecção Hospitalar/epidemiologia , Humanos , Higiene , Ceratoconjuntivite/epidemiologia , Ceratoconjuntivite/prevenção & controle , Neomicina/administração & dosagem , Soluções Oftálmicas , Povidona-Iodo/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA